ARYZTA AG NAM. SF-,02/ CH0043238366 /
28/06/2019 00:00:00 | Chg. - | Volume | Bid- | Demandez à- | Capitalisation boursière | Dividende Y. | Rapport P/E |
---|---|---|---|---|---|---|---|
0.967EUR | - | 0 Chiffrre d'affaires: 0.000 |
-Bid taille: - | -Ask la taille: - | 1.72 Mrd.EUR | - | 17.88 |
GlobeNewswire
16:17
TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Investors...
GlobeNewswire
16:11
ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
16:00
SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
GlobeNewswire
15:50
ENPH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors ...
GlobeNewswire
15:48
PATH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that UiPath, Inc. Investors with ...
GlobeNewswire
15:45
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action...
GlobeNewswire
15:00
ROSEN, A LEADING LAW FIRM, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Import...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page